Chemotherapy for advanced epithelial ovarian carcinoma

This publication has 66 references indexed in Scilit:

• Age does not influence taxol dose intensity in recurrent carcinoma of the ovary
  Cancer, 2010
• Treatment of advanced ovarian cancer
  European Journal Of Cancer, 2001
• Cancer Statistics, 2001
  CA: A Cancer Journal for Clinicians, 2001
• Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results
  JNCI Journal of the National Cancer Institute, 2000
• Stage IV Ovarian Cancer: Impact of Surgical Debulking1
  Gynecologic Oncology, 1997
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• Long-term survival in ovarian cancer
  European Journal of Cancer and Clinical Oncology, 1991
• The ‘failure free interval’ defines the likelihood of resistance to carboplatin in patients with advanced epithelial ovarian cancer previously treated with cisplatin: relevance to therapy and new drug testing
  International Journal of Gynecologic Cancer, 1991
• Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian Cancer
  New England Journal of Medicine, 1990
• Announcement
  Gynecologic Oncology, 1986